Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology

被引:52
作者
Johnson, VJ [1 ]
Yucesoy, B [1 ]
Luster, MI [1 ]
机构
[1] Ctr Dis Control & Prevent, Toxicol & Mol Biol Branch, Hlth Effects Lab Div, NIOSH, Morgantown, WV 26505 USA
关键词
polymorphism; cytokine; single nucleotide polymorphism (SNP); real-time PCR; Taqman;
D O I
10.1016/j.cyto.2004.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Single nucleotide polymorphisms (SNPs), particularly those within regulatory regions of genes that code for cytokines often impact expression levels and can be disease modifiers. Investigating associations between cytokine genotype and disease outcome provides valuable insight into disease etiology and potential therapeutic intervention. Traditionally, genotyping for cytokine SNPs has been conducted using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), a low throughput technique not amenable for use in large-scale cytokine SNP association studies. Recently, Taqman(R) real-time PCR chemistry has been adapted for use in allelic discrimination assays. The present study validated the accuracy and utility of real-time PCR technology for a number of commonly studied cytokine polymorphisms known to influence chronic inflammatory diseases. We show that this technique is amenable to high-throughput genotyping and overcomes many of the problematic features associated with PCR-RFLP including post-PCR manipulation, non-standardized assay conditions, manual allelic identification and false allelic identification due to incomplete enzyme digestion. The real-time PCR assays are highly accurate with an error rate in the present study of <1% and concordance rate with PCR-RFLP genotyping of 99.4%. The public databases of cytokine polymorphisms and validated genotyping assays highlighted in the present study will greatly benefit this important field of research. Published by Elsevier Ltd.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 22 条
[1]   The essence of SNPs [J].
Brookes, AJ .
GENE, 1999, 234 (02) :177-186
[2]   A multilocus genotyping assay for candidate markers of cardiovascular disease risk [J].
Cheng, S ;
Grow, MA ;
Pallaud, C ;
Klitz, W ;
Erlich, HA ;
Visvikis, S ;
Chen, JJ ;
Pullinger, CR ;
Malloy, MJ ;
Siest, G ;
Kane, JP .
GENOME RESEARCH, 1999, 9 (10) :936-949
[3]   Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis [J].
de Jong, BA ;
Westendorp, RGJ ;
Eskdale, J ;
Uitdehaag, BMJ ;
Huizinga, TWJ .
HUMAN IMMUNOLOGY, 2002, 63 (04) :281-285
[4]   Comparison of methods for determination of interleukin 6 G(-174)C promoter polymorphism [J].
Häring, D ;
Endler, G ;
Hsieh, K ;
Mannhalter, C .
BIOTECHNIQUES, 2002, 33 (05) :1114-1117
[5]   Cytokine gene polymorphism in human disease: on-line databases, Supplement 2 [J].
Haukim, N ;
Bidwell, JL ;
Smith, AJP ;
Keen, LJ ;
Gallagher, G ;
Kimberly, R ;
Huizinga, T ;
McDermott, MF ;
Oksenberg, J ;
McNicholl, J ;
Pociot, F ;
Hardt, C ;
D'Alfonso, S .
GENES AND IMMUNITY, 2002, 3 (06) :313-330
[6]   Application of SNP technologies in medicine: Lessons learned and future challenges [J].
Lai, E .
GENOME RESEARCH, 2001, 11 (06) :927-929
[7]   Reading bits of genetic information: Methods for single-nucleotide polymorphism analysis [J].
Landegren, U ;
Nilsson, M ;
Kwok, PY .
GENOME RESEARCH, 1998, 8 (08) :769-776
[8]  
Lario S, 1999, CLIN CHEM, V45, P1290
[9]   Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease [J].
Lazarus, R ;
Vercelli, D ;
Palmer, LJ ;
Klimecki, WJ ;
Silverman, EK ;
Richter, B ;
Riva, A ;
Ramoni, M ;
Martinez, FD ;
Weiss, ST ;
Kwiatkowski, DJ .
IMMUNOLOGICAL REVIEWS, 2002, 190 (01) :9-25
[10]   The use of single-nucleotide polymorphism maps in pharmacogenomics [J].
McCarthy, JJ ;
Hilfiker, R .
NATURE BIOTECHNOLOGY, 2000, 18 (05) :505-508